Covid-19 Vaccine Matters

New

September 8, 2021

Full Approval: What Does FDA Approval for the Pfizer COVID-19 Vaccine Mean for Mandates? Hesitancy? The Fall?

By Chris Beyrer

August 16, 2021

Vaccination and the Delta Variant: Four Steps Forward, Two Steps Back

By Larry Corey

July 23, 2021

Tale of Two Intersecting Epidemics: Why We Need mRNA Vaccines in Africa, and For All Who Are Immunocompromised

By Larry Corey, Chris Beyrer, MD, MPH

June 30, 2021

Immunocompromised People Are Vulnerable to COVID-19. We Owe Them Some Answers.

By Larry Corey

April 28, 2021

A Commentary on the Adverse Side Effects of the COVID-19 Adenovirus-Based Vaccines

By Larry Corey

April 16, 2021

The Full Picture: Accurately Framing COVID-19 Vaccine ‘Hesitancy’ among Black Americans

By Allysha C. Maragh-Bass, Louis B. Shackelford

March 29, 2021

Is Covid Vaccination the Solution to the Covid-19 Crisis Affecting Older Adults in Long-Term Care?

By Alison Roxby, MD, MSc

March 18, 2021

With an RNA Virus, the Past Doesn’t Predict the Future

By Larry Corey

March 9, 2021

Vaccination, Transmission, and Masks

By Chris Beyrer, MD, MPH, Larry Corey

March 2, 2021

J&J Vaccine: Finally, One Dose with No Controversy

By Larry Corey

February 25, 2021

When will children and adolescents be vaccinated against Covid-19?

By Anna Durbin, William Moss, Kawsar Talaat, Ruth A. Karron

January 31, 2021

The Virus’s Gambit; The Vaccine Response

By Larry Corey

January 15, 2021

Two Doses or One? COVID-19 Vaccine Regimens

By Chris Beyrer, Larry Corey

January 5, 2021

COVID-19 Vaccines Are Rolling Out. Should I Be Worried?

By William Moss

December 22, 2020

Science in the face of fear: a commentary on vaccine hesitancy and public trust

By Larry Corey

December 9, 2020

FAQ: Emergency Use Authorizations (EUAs) and COVID-19 Vaccines

By Ruth A. Karron, Jessica E. Atwell

December 9, 2020

A Band of Brothers…and Sisters

By Larry Corey

December 3, 2020

The Coming COVID-19 Vaccine Scarcity

By Larry Corey

November 24, 2020

Why Diversity and Inclusion Matter in the COVID-19 Vaccine Trials

By Chris Beyrer, Michele Andrasik

November 16, 2020

The messenger RNA vaccines and masks

By Larry Corey

November 11, 2020

Will a COVID-19 Vaccine Benefit You? (Or Me?)

By Larry Corey

Overview

Full Approval: What Does FDA Approval for the Pfizer COVID-19 Vaccine Mean for Mandates? Hesitancy? The Fall?

Vaccination and the Delta Variant: Four Steps Forward, Two Steps Back

Tale of Two Intersecting Epidemics: Why We Need mRNA Vaccines in Africa, and For All Who Are Immunocompromised

Immunocompromised People Are Vulnerable to COVID-19. We Owe Them Some Answers.

A Commentary on the Adverse Side Effects of the COVID-19 Adenovirus-Based Vaccines

The Full Picture: Accurately Framing COVID-19 Vaccine ‘Hesitancy’ among Black Americans

Is Covid Vaccination the Solution to the Covid-19 Crisis Affecting Older Adults in Long-Term Care?

With an RNA Virus, the Past Doesn’t Predict the Future

Vaccination, Transmission, and Masks

J&J Vaccine: Finally, One Dose with No Controversy

When will children and adolescents be vaccinated against Covid-19?

The Virus’s Gambit; The Vaccine Response

Two Doses or One? COVID-19 Vaccine Regimens

COVID-19 Vaccines Are Rolling Out. Should I Be Worried?

Science in the face of fear: a commentary on vaccine hesitancy and public trust

FAQ: Emergency Use Authorizations (EUAs) and COVID-19 Vaccines

A Band of Brothers…and Sisters

The Coming COVID-19 Vaccine Scarcity

Why Diversity and Inclusion Matter in the COVID-19 Vaccine Trials

The messenger RNA vaccines and masks

Will a COVID-19 Vaccine Benefit You? (Or Me?)